论文部分内容阅读
目的了解我院神经内科脑血栓形成住院患者药品使用情况,降低医药成本,指导临床合理用药。方法采用临床治疗回顾调查方法,收集我院神经内科2009年1月～2011年12月期间,CT诊断印象为右侧基底节低密度影为主的脑血栓形成住院患者,使用注射用脑血管病类药物的频率分析、金额排序、用药剂量、用药天数、药物利用指数等,分析临床用药情况。结果 DDDs排序居前的品种:中成药注射剂有银杏叶注射液、葛根素注射液、天麻素注射液、疏血通注射液,脑血管类西药注射剂有尼莫地平注射液、脑蛋白水解物注射液,抗血小板西药注射剂有奥扎格雷注射液。用药频率DDDs排序居前,临床使用情况占主导地位,DDDs排序居前的品种每日费用较低。结论我院神经内科在选择脑血管病用药方面基本合理,但应进一步加强对脑血管病选择使用药品的监督管理,降低医疗成本,减轻患者负担,提高医疗机构整体管理水平。
Objective To understand the use of drugs in hospitalized patients with cerebral thrombosis in our department of neurology, reduce the cost of medicine, and guide clinical rational use of drugs. Methods The retrospective investigation of clinical treatment methods to collect the Department of Neurology in our hospital from January 2009 to December 2011 period, the diagnosis of CT as the right basal ganglia low density-based cerebral thrombosis inpatients, the use of injection of cerebrovascular disease Frequency analysis of drugs, the amount of sorting, dosage, medication days, drug utilization index, analysis of clinical medication. Results DDDs ranked the top varieties: proprietary Chinese medicine injection Ginkgo biloba injection, puerarin injection, gastrodin injection, Shuxuetong injection, cerebrovascular medicine injection nimodipine injection, brain protein hydrolyzate injection Liquid, anti-platelet western medicine injection Ozagrel injection. Dosage DDDs ranked first, the clinical use of the dominant position, DDDs ranked the top species lower daily cost. Conclusion Neurology in our hospital is basically reasonable in the selection of medication for cerebrovascular disease. However, the supervision and management of the selective use of drugs for cerebrovascular disease should be further strengthened to reduce the medical costs, reduce the burden on patients and improve the overall management level of medical institutions.